Following the initial results in breast cancer, uPA overexpression was shown to confer a worse prognosis in many other cancers including colorectal, esophageal, gastric, hepatocellular, prostate, sarcoma, and head and neck squamous cells among others [6–12]. This evidence concerns the gene PLAU and breast cancer.